Newsletter | April 8, 2026

04.08.26 -- Does Biotech Need More (Government) Funding — Or A New Growth Model?

SPONSOR

Join Outsourced Pharmaceutical Live’s Jeff Buguliskis and panelists on April 22nd at 11 AM Eastern for One Program, Many CDMOs: Managing Multi-Partner Strategies. Registration for this virtual event is free thanks to sponsor Thermo Fisher.

INDUSTRY INSIGHTS

Expanding The OSD Toolbox With Lipid‑Loaded Powders

Case Study | By Bobby Sciscento, Alcami

Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.

Mastering Modern Challenges In Drug Development

White Paper | Thermo Fisher Scientific

Drawing on experience from hundreds of successful transfers, our experts recognize that informed decision-making at critical junctures can determine whether a program maintains momentum or loses it.

Breaking Barriers: Enhancing The Bioavailability Of Orally Delivered TPDs

Article | By Rebecca Coutts, Ph.D., PCI Pharma Services

The large, bulky structure of TPDs limits solubility and permeability. Enabling technologies like spray drying, hot melt extrusion, and nanomilling are key to formulating these challenging molecules.

FEATURED EDITORIAL

Does Biotech Need More (Government) Funding — Or A New Growth Model?

By Louis Garguilo, chief editor, Outsourced Pharma

Biotechs have been able to present to investors primarily as a scientific enterprise; manufacturing concerns remained downstream, to be addressed at some future point. Increasingly, investors want to know, “Who is your scale-up and manufacturing partner?” Maybe that's now more important than how much government funding a biotech has been able to raise. The outsourcing decision itself becomes part of the investment thesis. How do we weld this into a model investors will jump into?

Global Clinical Supply — Confronting Persistent Challenges With Strategic Action

By Rodney E. Rohde, Ph.D., Global Translational Health Leader

From regulatory fragmentation to cold chain risks, discover how strategic action, data visibility, and resilient design keep clinical trials on track.

INDUSTRY INSIGHTS CONTINUED

Identify And Mitigate Absorption Risks With PBPK Modeling

Webinar | Lonza

See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

Increasing Bioavailability With Amorphous Solid Dosage Formulations

White Paper | Lonza

Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

The Best Regulatory Practices For Lifecycle Management

E-Book | BioPhorum

Assimilate how Quality by Design strategies can reduce regulatory burden, simplify post-approval changes, and improve lifecycle flexibility while maintaining product quality and supply continuity.

SOLUTIONS

Advances In AI‑Driven Drug Development

View support for your next small molecule drug substance program and learn how artificial intelligence and machine learning tools can be applied to accelerate API development.

Accelerating FIH Trials To POC With Speed, Safety, And Certainty

Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.

Pharmaceutical Formulation Development

Proper API formulation is critical for therapeutic efficacy. Learn more about patient safety, product stability, optimized pharmacokinetics, regulatory compliance, and more.

OUTSOURCED PHARMA CAPABILITIES UPDATE

Find Your New CDMO At Outsourced Pharma Capabilities Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: